Company Summary
Search
Home Page
 
Sernova Corp. 
Listed Company 
Current   Past  
Fiscal Year EndCompany StatusExempt Flag
October 31TradingN
Incorporation Locations
Inc. DateExpiry DateCountryRegionDescription
19/Aug/1998  Canada British Columbia  
Exchange Filing Office
Location
Vancouver Regional Service Office
Business Type(s)
Primary/SecondaryBusiness TypeDetails
Primary  Research And Development In The Life Sciences  News Release June 3, 2014 -Sernova Corp is a clinical stage regenerative medicine company developing medical technologies for the treatment of chronic debilitating metabolic diseases such as diabetes, blood disorders including haemophilia and other diseases treated through replacement of proteins or hormones missing or in short supply within the body. Sernova is developing the Cell Pouch?, an implantable medical device for therapeutic cells (donor, xenogeneic or stem cells) which then release proteins and/or hormones as required. The therapeutic cells are protected from immune attack by Sernova's proprietary technologies. 
Securities
SymbolSecurity NameMarketStatus
SVASernova Corp.TSX VentureTRADING
Name HistoryFromTo
Sernova Corp.20/Sep/2006Present
Company Facts Reconciliation
SubjectDate Returned
Spring 2015 CFR Not Received
Associations
Auditing Firm:  Davidson & Company LLP
Subsidiary:  Sertocell Biotechnology (US) Corp.
Transfer Agent:  CST Trust Company
Latest Information
TypeDateTitle
News Releases  1/Aug/2018  NEWS RELEASE - PRIVATE PLACEMENT NON BROKERED[MARKET NEWS]
    NEWS RELEASE - COMPLETES OVERSUBSCRIBED PRIVATE PLACEMENT OF $2[MARKET NEWS]
    NEWS RELEASE - SERNOVA PROVIDES COMPANY OUTLOOK ON CORPORATE AND CLINICAL DEVELOPMENTS[MARKETWIRE]
Bulletins  25/Jun/2020  Convertible Debentures
Meetings and Public Filings  Information on financial statements, public filings and corporate meetings for all Canadian public companies can be found at www.sedar.com
Property Locations
(not available)

* Historical Data